Published in J Clin Invest on September 15, 1997
Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun (2000) 3.42
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun (1999) 2.22
Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol (2011) 1.98
Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev (2001) 1.72
Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol (2008) 1.59
Cryptococcal interactions with the host immune system. Eukaryot Cell (2010) 1.57
Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog (2008) 1.53
The role of Toll-like receptors in renal diseases. Nat Rev Nephrol (2010) 1.42
Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Infect Immun (2000) 1.38
Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun (2005) 1.17
Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH. MBio (2011) 1.15
Fungal adaptation to the mammalian host: it is a new world, after all. Curr Opin Microbiol (2008) 1.15
Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun (2008) 1.07
The intracellular life of Cryptococcus neoformans. Annu Rev Pathol (2013) 1.06
Intracellular pathogenic bacteria and fungi--a case of convergent evolution? Nat Rev Microbiol (2008) 1.06
Cell wall perturbation sensitizes fungi to the antimalarial drug chloroquine. Antimicrob Agents Chemother (2013) 1.04
Novel paradigms for drug discovery: computational multitarget screening. Trends Pharmacol Sci (2008) 1.03
Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens. Eukaryot Cell (2007) 1.00
The CovS/CovR acid response regulator is required for intracellular survival of group B Streptococcus in macrophages. Infect Immun (2012) 0.98
The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes. BMC Microbiol (2009) 0.98
Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci. PLoS One (2010) 0.97
A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis. Eukaryot Cell (2012) 0.94
Antifungal activity of nonantifungal drugs. Eur J Clin Microbiol Infect Dis (2003) 0.92
Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans. J Infect Chemother (2011) 0.87
Quinine sulfate and bacterial invasion. Ann Clin Microbiol Antimicrob (2002) 0.81
Inhibition of intramacrophage growth of Penicillium marneffei by 4-aminoquinolines. Antimicrob Agents Chemother (2001) 0.79
Differential modulation of intracellular survival of cytosolic and vacuolar pathogens by curcumin. Antimicrob Agents Chemother (2012) 0.79
Signaling of chloroquine-induced stress in the yeast Saccharomyces cerevisiae requires the Hog1 and Slt2 mitogen-activated protein kinase pathways. Antimicrob Agents Chemother (2014) 0.78
Cryptococcus neoformans: Tripping on Acid in the Phagolysosome. Front Microbiol (2016) 0.78
Cytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Cryptococcus neoformans. Infect Immun (2001) 0.78
Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin. J Inflamm Res (2015) 0.76
Synergistic activity of chloroquine with fluconazole against fluconazole-resistant isolates of Candida species. Antimicrob Agents Chemother (2014) 0.75
Reply to "chloroquine, an antifungal but also a fertility drug". Antimicrob Agents Chemother (2013) 0.75
Quinacrine inhibits Candida albicans growth and filamentation at neutral pH. Antimicrob Agents Chemother (2014) 0.75
Secretory products of macrophages. J Clin Invest (1987) 10.33
pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A (1983) 8.41
The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis (1992) 2.94
Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect Immun (1995) 2.52
Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun (1994) 2.41
Growth of Cryptococcus neoformans within human macrophages in vitro. Infect Immun (1973) 2.39
Cryptococcal meningitis and AIDS. Clin Infect Dis (1993) 2.03
Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect Immun (1988) 1.94
Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases. Am J Clin Pathol (1955) 1.93
Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med (1993) 1.82
Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun (1991) 1.80
Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J Clin Invest (1991) 1.70
Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest (1991) 1.68
Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect Immun (1990) 1.62
Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. N Engl J Med (1987) 1.60
Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun (1994) 1.57
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest (1994) 1.56
Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun (1991) 1.54
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother (1994) 1.48
The kinetics and mechanism of iron(3) exchange between chelates and transferrin. IV. The reaction of transferrin with iron(3) nitrilotriacetate. J Biol Chem (1971) 1.38
Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol (1991) 1.34
Pharmacologic actions of 4-aminoquinoline compounds. Am J Med (1983) 1.27
Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther (1996) 1.21
Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses (1993) 1.17
Acquisition of iron by Legionella pneumophila: role of iron reductase. Infect Immun (1991) 1.16
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A. Infect Immun (1986) 1.16
Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans. Infect Immun (1991) 1.14
Some factors which affect the initiation of growth of Cryptococcus neoformans. J Bacteriol (1961) 1.13
Macrophage-Cryptococcus interactions. Immunol Ser (1994) 1.13
Extracellular iron chelation in Cryptococcus neoformans. J Med Vet Mycol (1987) 1.06
Lysosomal origin of the ferric iron required for cell killing by hydrogen peroxide. Biochem Biophys Res Commun (1985) 1.02
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02
Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J Immunol (1996) 1.01
Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis. Antimicrob Agents Chemother (1997) 1.01
Chloroquine attenuates hemorrhagic shock-induced immunosuppression and decreases susceptibility to sepsis. Arch Surg (1992) 0.99
Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3. Antimicrob Agents Chemother (1990) 0.96
Subcellular localization of ferritin and iron taken up by rat hepatocytes. Biochem J (1989) 0.95
Acquisition of iron bound to low molecular weight chelates by human monocyte-derived macrophages. J Immunol (1994) 0.94
Iron acquisition by Cryptococcus neoformans. J Med Vet Mycol (1995) 0.93
Uptake of ferritin and iron bound to ferritin by rat hepatocytes: modulation by apotransferrin, iron chelators and chloroquine. Biochim Biophys Acta (1989) 0.93
Binding of Cryptococcus neoformans to heterologously expressed human complement receptors. Infect Immun (1997) 0.91
Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription. Immunology (1993) 0.87
Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5-trisphosphate binding to its receptor. J Cell Biochem (1997) 0.87
Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans. Infect Immun (1997) 0.87
The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes. J Infect Dis (1995) 0.86
Experimental systemic cryptococcosis in SCID mice. J Med Vet Mycol (1997) 0.84
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (1997) 16.09
Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genet (2001) 13.05
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell (1997) 12.83
An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem (1999) 6.88
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science (2001) 6.84
PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1999) 4.90
Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell (1995) 4.73
Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell (1991) 4.66
Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell (2000) 4.51
Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31
SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol (2000) 4.30
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet (2000) 3.63
Statistical power and optimal design for multisite randomized trials. Psychol Methods (2000) 3.58
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54
Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am J Physiol Regul Integr Comp Physiol (2003) 3.37
Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release (2009) 3.08
CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene (2011) 3.08
Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science (2001) 2.97
Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1. J Med Genet (2006) 2.97
Lead exposure and intelligence in 7-year-old children: the Yugoslavia Prospective Study. Environ Health Perspect (1997) 2.88
Effects of clonidine withdrawal: possible mechanisms and suggestions for management. Br Med J (1973) 2.87
Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79
The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci U S A (2001) 2.75
Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther (1999) 2.73
A transmission/disequilibrium test that allows for genotyping errors in the analysis of single-nucleotide polymorphism data. Am J Hum Genet (2001) 2.68
Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology (2009) 2.60
Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev (1994) 2.54
Assembly of Trp1 in a signaling complex associated with caveolin-scaffolding lipid raft domains. J Biol Chem (2000) 2.43
Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed (1999) 2.41
Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. Mol Endocrinol (1997) 2.34
Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J (1992) 2.29
Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev (1998) 2.29
An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet (1995) 2.26
The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol (2001) 2.25
NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene (2011) 2.22
Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun (1999) 2.22
Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol (2012) 2.18
An epidemiological study of insomnia among the Japanese general population. Sleep (2000) 2.09
Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci (2001) 2.09
Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway. Oncogene (2007) 2.07
SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci U S A (1999) 2.06
Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem (2001) 2.06
Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci (2001) 2.05
Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry (2002) 2.05
Social networks, social support, and mortality among older people in Japan. J Gerontol (1994) 2.01
Predicting global atmospheric ice nuclei distributions and their impacts on climate. Proc Natl Acad Sci U S A (2010) 2.00
Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development (1999) 2.00
Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A (2004) 1.99
The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes (2004) 1.96
DOS, a novel pleckstrin homology domain-containing protein required for signal transduction between sevenless and Ras1 in Drosophila. Cell (1996) 1.94
Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol Cell (1999) 1.91
G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. Science (2001) 1.90
Reduced neurogenesis after neonatal seizures. J Neurosci (2001) 1.89
Molecular interactions between Vestigial and Scalloped promote wing formation in Drosophila. Genes Dev (1998) 1.89
Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci U S A (1994) 1.88
Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation (2001) 1.88
Nanolitre liquid patterning in aqueous environments for spatially defined reagent delivery to mammalian cells. Nat Mater (2009) 1.87
Efficient asymmetric synthesis of biologically important tryptophan analogues via a palladium-mediated heteroannulation reaction. J Org Chem (2001) 1.85
Improved dual-energy material discrimination for dual-source CT by means of additional spectral filtration. Med Phys (2009) 1.85
Deficiency in fatty acid synthase leads to premature cell death and dramatic alterations in plant morphology. Plant Cell (2000) 1.84
Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet (1995) 1.83
Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol (1998) 1.82
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ (2009) 1.82
Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation (1999) 1.82
Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry (2000) 1.81
Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med (1997) 1.81
Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci U S A (1997) 1.80
A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem (2001) 1.77
Synaptotagmin VII as a plasma membrane Ca(2+) sensor in exocytosis. Neuron (2001) 1.76
The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell (2001) 1.76
Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol (2001) 1.75
The Golgi-associated hook3 protein is a member of a novel family of microtubule-binding proteins. J Cell Biol (2001) 1.75
Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res (1995) 1.75
Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology (2004) 1.73
Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem (2001) 1.71
Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J Clin Invest (1991) 1.70
MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics (2001) 1.70
Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. J Biol Chem (2000) 1.70
Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol Cell (1999) 1.69
A novel GJA8 mutation is associated with autosomal dominant lamellar pulverulent cataract: further evidence for gap junction dysfunction in human cataract. J Med Genet (2006) 1.68
A statistically valid alternative to the TDT. Hum Hered (2002) 1.67
Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci U S A (2000) 1.67
Site-directed isotope labelling and FTIR spectroscopy of bacteriorhodopsin. Nat Struct Biol (1994) 1.67
Factors associated with use of mental health services for depression by children and adolescents. Psychiatr Serv (2001) 1.65
Peripheral Golgi protein GRASP65 is a target of mitotic polo-like kinase (Plk) and Cdc2. Proc Natl Acad Sci U S A (2000) 1.62
Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res (2001) 1.60
Heat shock transcription factor activates yeast metallothionein gene expression in response to heat and glucose starvation via distinct signalling pathways. Mol Cell Biol (1994) 1.60
Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum (2001) 1.60
Evaluation of an emergency department-based injury surveillance project in China using WHO guidelines. Inj Prev (2009) 1.60
Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol (1996) 1.59
Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice. Nat Genet (1998) 1.58
Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun (1994) 1.57
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Outcomes of a population-based asthma management program: quality of life, absenteeism, and utilization. Ann Allergy Asthma Immunol (2000) 1.55
An experimental evaluation of a loop versus a reference design for two-channel microarrays. Bioinformatics (2004) 1.54
Results on neutrinoless double-β decay of 76Ge from phase I of the GERDA experiment. Phys Rev Lett (2013) 1.54
CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction. J Gen Physiol (2001) 1.53